- Report
- August 2025
- 197 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2025
- 187 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
From €3140EUR$3,500USD£2,684GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3140EUR$3,500USD£2,684GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3140EUR$3,500USD£2,684GBP
- Report
- August 2024
- 80 Pages
Japan
From €3140EUR$3,500USD£2,684GBP
- Report
- May 2024
- 182 Pages
Global
From €4037EUR$4,500USD£3,451GBP
- Report
- October 2023
- 145 Pages
Global
From €2826EUR$3,150USD£2,416GBP
- Drug Pipelines
- April 2025
- 204 Pages
Global
From €2691EUR$3,000USD£2,301GBP
- Report
- October 2022
- 200 Pages
Global
From €2646EUR$2,950USD£2,262GBP
- Report
- April 2023
- 147 Pages
Global
From €4440EUR$4,949USD£3,795GBP
- Report
- April 2023
- 147 Pages
Global
From €4440EUR$4,949USD£3,795GBP
- Report
- May 2025
- 138 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- January 2025
- 53 Pages
Global
From €2242EUR$2,499USD£1,916GBP

Gene Silencing is a biotechnology process that involves the suppression of gene expression. It is used to study gene function, identify gene targets for drug discovery, and develop gene therapies. Gene silencing can be achieved through a variety of methods, including RNA interference (RNAi), antisense technology, and epigenetic modifications. RNAi is the most widely used gene silencing technique, as it is a highly specific and efficient method of gene suppression.
Gene silencing has become an important tool in the biotechnology industry, as it can be used to study gene function, identify gene targets for drug discovery, and develop gene therapies. It has also been used to develop new crop varieties with improved traits, such as disease resistance and increased yield.
Companies in the gene silencing market include Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Illumina, Inc., and New England Biolabs. Show Less Read more